Leidos (NYSE: LDOS ), a national security, health and engineering solutions company, was awarded a prime contract by the U.S. Army Research Laboratory (ARL) to provide intelligence, surveillance and reconnaissance (ISR) concepts research and development (R&D). The multiple-award cost-plus fixed-fee indefinite-delivery indefinite-quantity contract has a five-year period of performance and a total contract value of approximately $49 million for all awardees. Work will be performed primarily at the ARL in Adelphi, Md. Leidos is one of seven awardees eligible to compete for task orders under the contract.
The ARL's mission is to discover, innovate, and transition science and technology to ensure dominant strategic land power. Under the contract, Leidos will have the opportunity to provide ISR R&D, including operational, program management, technical, engineering, integration, and program and product support services. Services will encompass a wide variety of advanced technology support to include analysis, studies, development, design, and demonstration of innovative ISR concepts and prototype technologies.
"We look forward to providing the Army Research Laboratory advanced technology support and innovative ISR concepts to increase technical performance, improve reliability and reduce costs of existing products and systems," said Leidos Group President, John Fratamico . "Leidos is proud to continue supporting the Army Research Laboratory and further our commitment to strengthening national defense."
Date: Jul 16, 2015